webinar register page

Paraneoplastic Evolution – Q&A Discussion

Overview:
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research lab, clinical lab and Autoimmune Neurology Clinic, we have developed evaluations customized to address specific neurological phenotypes. This approach delivers more clinically actionable results, providing a clear picture of the diagnosis, prognosis and treatment options. Understanding the rationale for this evolution will be important for physicians and lab directors to more efficiently utilize the available laboratory testing.

Learning objectives:
1) Discuss shortcomings of traditional paraneoplastic approach to autoantibody testing
2) Describe the clinical relevance of neural antibodies on patient diagnosis, prognosis and treatment
3) Appreciate the role of unclassified antibodies and the future of autoimmune neurology testing

Sep 14, 2022 02:00 PM in Central Time (US and Canada)